EUVIMEDEUVIMED entdecken
Crossref

Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation

Matheus Wohlfahrt Baumgarten, Iuri Martin Goemann, Rafael Selbach Scheffel, Ana Luiza Maia

Clinical Breast Cancer · 2024

DOI: 10.1016/j.clbc.2024.04.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2024. Verfasst von Matheus Wohlfahrt Baumgarten und 3 weiteren Autor:innen. Beteiligte Einrichtung: Thyroid Unit, Hospital de Clínicas de Porto Alegre, Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Hauptthemen laut MEDLINE: Breast Neoplasms, Thyroid Neoplasms, SEER Program. Die Arbeit nennt 26 Literaturangaben. Gefördert von: National Council for Scientific and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Previous studies have reported a strong correlation between breast cancer (BC) and thyroid cancer (TC) incidence. However, the clinical and oncological impact of these associations are not yet fully understood. Here, we aimed to explore the differences in clinicopathological characteristics between TC patients with and without BC, and the effect of a history of positive BC on TC survival. METHODS: We retrospectively compared the clinical characteristics and survival rates of patients with TC alone and those with TC and BC in a primary cohort at our institution and in a second cohort using the Surveillance, Epidemiology, and End Results (SEER) database. RESULTS: In our institutional cohort, survival rates were similar between patients with TC alone and those with TC-associated BC. However, using SEER data, we found that BC had a protective effect on TC patients and was associated with reduced TC mortality rates (hazard ratio [HR] = 0.72, 95% confidence interval [CI] 0.57 to 0.92; P = .026). After stratifying the TC patients according to co-occurring BC subtypes, we observed that higher survival rates were restricted to patients with coexisting luminal A BC (P = .015), which exhibit positive hormone receptors and do not express HER-2. CONCLUSION: These findings suggest that hormone pathways may play a role in the co-occurrence of thyroid and breast cancers. Patients with TC coexisting with luminal A BC have higher survival rates. However, further studies on the mechanisms underlying the association between BC and TC are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsThyroid NeoplasmsSEER ProgramHumansFemaleMiddle AgedRetrospective StudiesSurvival RateAgedAdultPrognosisErb-b2 Receptor Tyrosine Kinases

Stichwörter der Autor:innen

Breast neoplasmPrognosisSecond primary cancerSurveillance, Epidemiology, and End Results (SEER)Survival ratesThyroid cancer

Substanzen

Erb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Thyroid Unit, Hospital de Clínicas de Porto Alegre, Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • Thyroid Unit, Hospital de Clínicas de Porto Alegre, Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; Medical School, Universidade do Vale do Rio dos Sinos, São Leopoldo, Brazil.
  • Thyroid Unit, Hospital de Clínicas de Porto Alegre, Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; Department of Pharmacology, Instituto de Ciências Básicas da Saúde, Universidade Feder…
  • Thyroid Unit, Hospital de Clínicas de Porto Alegre, Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Electronic address: almaia@ufrgs.br.

Förderung

  • National Council for Scientific and Technological Development

Zitieren

APA

Baumgarten, M. W., Goemann, I. M., Scheffel, R. S., & Maia, A. L. (2024). Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2024.04.002

Vancouver

Baumgarten MW, Goemann IM, Scheffel RS, Maia AL. Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation. Clinical Breast Cancer. 2024. doi:10.1016/j.clbc.2024.04.002

BibTeX
@article{Baumgarten2024,
  author = {Baumgarten, Matheus Wohlfahrt and Goemann, Iuri Martin and Scheffel, Rafael Selbach and Maia, Ana Luiza},
  title = {Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation},
  journal = {Clinical Breast Cancer},
  year = {2024},
  doi = {10.1016/j.clbc.2024.04.002}
}
Kostenlos starten →